RT Journal Article
SR Electronic
T1 Altitude as a protective factor from COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.03.20167262
DO 10.1101/2020.08.03.20167262
A1 Thomson, Timothy M.
A1 Casas, Fresia
A1 Guerrero, Harold Andre
A1 Figueroa-Mujíca, Rómulo
A1 Villafuerte, Francisco C.
A1 Machicado, Claudia
YR 2020
UL http://medrxiv.org/content/early/2020/08/04/2020.08.03.20167262.abstract
AB The COVID-19 pandemic had a delayed onset in South America compared to Asia (outside of China), Europe or North America. In spite of the presumed time advantage for the implementation of preventive measures to help contain its spread, the pandemic in that region followed growth rates that paralleled, and currently exceed, those observed several weeks before in Europe. Indeed, in early August, 2020, many countries in South and Central America presented among the highest rates in the world of COVID-19 confirmed cases and deaths per million inhabitants. Here, we have taken an ecological approach to describe the current state of the pandemic in Peru and its dynamics. Our analysis supports a protective effect of altitude from COVID-19 incidence and mortality. Further, we provide circumstantial evidence that internal migration through a specific land route is a significant factor progressively overriding the protection from COVID-19 afforded by high altitude. Finally, we show that protection by altitude is independent of poverty indexes and is inversely correlated with the prevalence in the population of risk factors associated with severe COVID-19, including hypertension and hypercholesterolemia. We discuss long-term multisystemic adaptations to hypobaric hypoxia as possible mechanisms that may explain the observed protective effect of high altitude from death from COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was partially funded by grants from the CSIC (COV19-006) and CIBER-EHD (Spain), awarded to T.M.T. F.C.V is supported by a Wellcome Trust Intermediate Research Fellowship in Public Health and Tropical Medicine.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This is an ecological analysis of COVID-19 cases registered in public databases.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript are available at the URLs below.https://www.inei.gob.pe/media/MenuRecursivo/publicaciones_digitales/Est/Lib1526/index.html.https://www.inei.gob.pe/media/MenuRecursivo/publicaciones_digitales/Est/Lib1718/Libro.pdfhttps://www.datosabiertos.gob.pe/group/datos-abiertos-de-covid-19https://covid19.minsa.gob.pe/sala_situacional.asphttps://cs.ucsp.edu.pe/monitor-covid/